Medical College of Wisconsin
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical College of Wisconsin sits in the top decile of US sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count).
Medical College of Wisconsin: 447 sponsored US clinical trials, 95 recruiting.
Medical College of Wisconsin sponsors 447 registered US clinical trials on ClinicalTrials.gov, 95 of them currently recruiting, and 236 completed. 28 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 10 trials.
Top-decile sponsor footprint
Medical College of Wisconsin ranks in the top decile of sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 286 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
447 total, page 4 of 9
Palmitic Acid and Human Microvascular Function
NCT06683534
GLP-1 RA on Liver OMICS in MASLD
NCT06982378
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
NCT07434544
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
NCT06594939
Oral Gallium Maltolate for Recurrent Glioblastoma
NCT07515924
Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy
NCT06884748
Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Temperature Management: Evaluation of Temple Touch Pro
NCT07507396
Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study
NCT07185204
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
NCT07218237
Moving Foward With Myeloma (MFM)
NCT07236502
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
NCT07111494
The Self-Sampling Pilot Study
NCT07085845
Exploring the Efficacy of Assistive Artificial Intelligence for Ultrasound Guided Regional Anesthesia in Residency Training
NCT06667401
Mobile Video Education to Improve Patient Clinician Communication During Prenatal Clinic Visits
NCT06323343
Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men
NCT04865341
Lidocaine Patches in Elderly Patients With Traumatic Rib Fractures
NCT05714631
Hand Dexterity Training in Degenerative Cervical Myelopathy (DCM)
NCT06754072
Pectointercostal Fascial Plane Block (PIFB) Alone Versus PIFB With Rectus Sheath Block (RSB) in Cardiac Surgery
NCT04908449
#iBeatCRC: A Community-based Intervention to Increase Early-onset Colorectal Cancer Awareness
NCT04715074
Effect of Plasma Ceramides on Peripheral Vascular Function
NCT05107869
BC Risk Assessment Before Top Surgery
NCT06239766
Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome
NCT05546814
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
NCT05325281
Patient-Clinician Communication Skill Training: A Mobile Education Initiative
NCT05100979
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
NCT05579782
Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children
NCT05343988
Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics
NCT05346406
Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease
NCT05357742
Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT05117008
CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies
NCT05094206
Inhibition of Oral Tumorigenesis by Antitumor B
NCT04278989
Social Risks-Focused Lifestyle Intervention to Reduce Preeclampsia (SAIL)
NCT04958057
Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection
NCT05144828
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
NCT05032820
Endothelial Function in Mechanical Circulatory Support
NCT04539093
Intervention to Improve Diabetes Outcomes in Older African American Women With Multi-Caregiving Burden
NCT04831697
Coagulation and Fibrinolysis of Estradiol in Transwomen
NCT05387577
Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers
NCT05120947
Observation vs Embolization in Severe Splenic Injury: A Randomized Controlled Trial
NCT05008172
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
NCT03459729
Defining the Neural Dynamics of Concept Retrieval Using Electrocorticography
NCT04620928
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
NCT04752384
Effect of Presenting Survival Information as Text or Pictograph During Periviable Birth Counseling
NCT04859114
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer
NCT04635059
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting
NCT05143554
Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
NCT04549259
Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold)
NCT04902911
Personal Sound Amplification Smartphone Application Feasibility
NCT03652909
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
NCT04477759
A Study of HD-tDCS and Cognitive Training to Improve Cognitive Function in MCI
NCT04246164
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 49 |
| Phase 2 | 80 |
| Phase 3 | 13 |
| Phase 4 | 15 |
Therapeutic Areas
What is open in the Medical College of Wisconsin pipeline
95 recruiting of 447 indexed (21% open); 236 completed (53%).
Phase mix: 28 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Stroke (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical College of Wisconsin: open-pipeline peers nationwide
Peers matched on 447 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 447 trials (± recruiting share)
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- University of Virginia · 449 trials · 22% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Colorado State University · 21% recruiting · 94 trials
- University of Louisville · 21% recruiting · 217 trials
- Ohio State University · 21% recruiting · 552 trials
- Nova Southeastern University · 21% recruiting · 71 trials
Related
What to do with this Medical College of Wisconsin page
447 registered trials is a research-attention snapshot, not an endorsement of Medical College of Wisconsin or any single study.
- 95 of Medical College of Wisconsin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical College of Wisconsin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medical College of Wisconsin pipeline card: 447 registered trials from official public datasets.Report a data error.